PAVmed CEO to Present at 2016 Marcum MicroCap Conference on June 2, 2016
May 26 2016 - 4:05PM
Business Wire
PAVmed Inc. (Nasdaq:PAVMU), an innovative, multi-product medical
device company developing and commercializing a diversified
pipeline of innovative products utilizing a groundbreaking business
model focused on capital efficiency and speed to market, today
announced that Lishan Aklog, M.D., PAVmed’s Chairman and Chief
Executive Officer, will present at the 2016 Marcum MicroCap
Conference on Thursday, June 2, 2016, at 3:30pm ET taking place in
New York City. Dr. Aklog will provide a corporate overview, discuss
the company’s innovative business model and review PAVmed’s five
lead products.
To access the live webcast of the presentation, please click
here. A replay will be available following the presentation.
About PAVmed
PAVmed Inc. is an innovative, multi-product medical device
company developing and commercializing a diversified pipeline of
innovative products which address unmet clinical needs. The
Company’s goal is to enhance and accelerate value creation by
employing a business model focused on capital efficiency and speed
to market. PAVmed is building a deep development product pipeline
with attractive regulatory pathways and market opportunities
encompassing a broad spectrum of clinical areas including carpal
tunnel syndrome, medical infusions, interventional radiology,
tissue ablation, and cardiovascular intervention. The Company is
further expanding its pipeline through engagements with clinician
innovators and leading academic medical centers.
Forward-Looking Statements
This press release includes forward-looking statements that
involve risks and uncertainties. Forward-looking statements are
statements that are not historical facts. Such forward-looking
statements, based upon the current beliefs and expectations of the
Company’s management, are subject to risks and uncertainties, which
could cause actual results to differ from the forward-looking
statements.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160526006398/en/
For PAVmed:Investors:Matthew
Ventimiglia,
212-599-1265mventimiglia@lazarpartners.comorMedia:Erich Sandoval,
213-908-6226esandoval@lazarpartners.com
Pavmed (MM) (NASDAQ:PAVMU)
Historical Stock Chart
From Feb 2025 to Mar 2025
Pavmed (MM) (NASDAQ:PAVMU)
Historical Stock Chart
From Mar 2024 to Mar 2025